久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/05/17 | 3,465 | 3,550 | 3,465 | 3,510 | +50 | +1.4% | 122,500 |
2022/05/16 | 3,610 | 3,615 | 3,450 | 3,460 | -105 | -2.9% | 181,000 |
2022/05/13 | 3,555 | 3,595 | 3,515 | 3,565 | +15 | +0.4% | 193,900 |
2022/05/12 | 3,600 | 3,610 | 3,535 | 3,550 | -30 | -0.8% | 179,300 |
2022/05/11 | 3,555 | 3,595 | 3,520 | 3,580 | -20 | -0.6% | 184,100 |
2022/05/10 | 3,480 | 3,610 | 3,475 | 3,600 | +140 | +4% | 219,000 |
2022/05/09 | 3,525 | 3,540 | 3,460 | 3,460 | -115 | -3.2% | 183,100 |
2022/05/06 | 3,580 | 3,595 | 3,545 | 3,575 | -30 | -0.8% | 175,500 |
2022/05/02 | 3,560 | 3,630 | 3,530 | 3,605 | +30 | +0.8% | 179,700 |
2022/04/28 | 3,405 | 3,580 | 3,405 | 3,575 | +180 | +5.3% | 328,300 |
2022/04/27 | 3,380 | 3,410 | 3,350 | 3,395 | -40 | -1.2% | 506,800 |
2022/04/26 | 3,415 | 3,455 | 3,410 | 3,435 | +50 | +1.5% | 181,300 |
2022/04/25 | 3,330 | 3,410 | 3,325 | 3,385 | +10 | +0.3% | 161,200 |
2022/04/22 | 3,360 | 3,405 | 3,360 | 3,375 | -85 | -2.5% | 166,300 |
2022/04/21 | 3,420 | 3,485 | 3,420 | 3,460 | +40 | +1.2% | 138,500 |
2022/04/20 | 3,390 | 3,450 | 3,365 | 3,420 | +40 | +1.2% | 169,400 |
2022/04/19 | 3,345 | 3,390 | 3,335 | 3,380 | +65 | +2% | 159,400 |
2022/04/18 | 3,350 | 3,370 | 3,300 | 3,315 | -70 | -2.1% | 184,000 |
2022/04/15 | 3,420 | 3,435 | 3,375 | 3,385 | -105 | -3% | 197,100 |
2022/04/14 | 3,520 | 3,545 | 3,465 | 3,490 | -15 | -0.4% | 149,400 |
2022/04/13 | 3,390 | 3,525 | 3,390 | 3,505 | +115 | +3.4% | 295,500 |
2022/04/12 | 3,495 | 3,500 | 3,370 | 3,390 | -110 | -3.1% | 249,300 |
2022/04/11 | 3,610 | 3,635 | 3,500 | 3,500 | -110 | -3% | 243,500 |
2022/04/08 | 3,740 | 3,750 | 3,595 | 3,610 | -60 | -1.6% | 334,400 |
2022/04/07 | 3,585 | 3,675 | 3,570 | 3,670 | +40 | +1.1% | 188,900 |
2022/04/06 | 3,685 | 3,720 | 3,625 | 3,630 | -80 | -2.2% | 129,400 |
2022/04/05 | 3,765 | 3,775 | 3,680 | 3,710 | -35 | -0.9% | 148,200 |
2022/04/04 | 3,675 | 3,745 | 3,655 | 3,745 | +85 | +2.3% | 122,000 |
2022/04/01 | 3,600 | 3,690 | 3,585 | 3,660 | ±0 | ±0% | 136,600 |
2022/03/31 | 3,730 | 3,755 | 3,660 | 3,660 | -115 | -3% | 204,000 |
2022/03/30 | 3,850 | 3,850 | 3,725 | 3,775 | -5 | -0.1% | 200,800 |
2022/03/29 | 3,780 | 3,780 | 3,720 | 3,780 | -5 | -0.1% | 178,900 |
2022/03/28 | 3,870 | 3,870 | 3,760 | 3,785 | -75 | -1.9% | 148,200 |
2022/03/25 | 3,860 | 3,860 | 3,785 | 3,860 | +50 | +1.3% | 220,400 |
2022/03/24 | 3,830 | 3,860 | 3,750 | 3,810 | -95 | -2.4% | 245,700 |
2022/03/23 | 3,795 | 3,905 | 3,765 | 3,905 | +155 | +4.1% | 262,000 |
2022/03/22 | 3,785 | 3,785 | 3,715 | 3,750 | ±0 | ±0% | 215,700 |
2022/03/18 | 3,810 | 3,820 | 3,700 | 3,750 | -50 | -1.3% | 372,400 |
2022/03/17 | 3,785 | 3,810 | 3,735 | 3,800 | +75 | +2% | 198,000 |
2022/03/16 | 3,750 | 3,765 | 3,710 | 3,725 | +25 | +0.7% | 143,600 |
2022/03/15 | 3,610 | 3,720 | 3,600 | 3,700 | +80 | +2.2% | 146,400 |
2022/03/14 | 3,600 | 3,670 | 3,600 | 3,620 | +15 | +0.4% | 141,600 |
2022/03/11 | 3,640 | 3,645 | 3,585 | 3,605 | -105 | -2.8% | 187,200 |
2022/03/10 | 3,645 | 3,715 | 3,595 | 3,710 | +135 | +3.8% | 308,500 |
2022/03/09 | 3,560 | 3,605 | 3,490 | 3,575 | +45 | +1.3% | 245,700 |
2022/03/08 | 3,430 | 3,565 | 3,425 | 3,530 | +65 | +1.9% | 247,200 |
2022/03/07 | 3,465 | 3,485 | 3,420 | 3,465 | -55 | -1.6% | 210,900 |
2022/03/04 | 3,550 | 3,570 | 3,505 | 3,520 | -65 | -1.8% | 174,700 |
2022/03/03 | 3,550 | 3,590 | 3,520 | 3,585 | +70 | +2% | 174,200 |
2022/03/02 | 3,585 | 3,595 | 3,505 | 3,515 | -105 | -2.9% | 214,700 |
751~
800
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
参天薬 | 161,400円 | -2.0% | -7.3% | 2.35% | 16.14倍 | 1.92倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 198,400円 | +8.4% | +0.2% | 2.12% | 14.42倍 | 1.73倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム